Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C7H14N2 |
| Molecular Weight | 126.1995 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 2 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)N=C=NC(C)C
InChI
InChIKey=BDNKZNFMNDZQMI-UHFFFAOYSA-N
InChI=1S/C7H14N2/c1-6(2)8-5-9-7(3)4/h6-7H,1-4H3
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Polymeric micelles in anticancer therapy: targeting, imaging and triggered release. | 2010-12 |
|
| tert-Butyl N-[(11-exo-benzyl-oxy-carbonyl-8-oxopenta-cyclo-[5.4.0.0.0.0]undecane-11-endo-yloxy)carbon-yl-methyl]carbamate. | 2010-09-25 |
|
| Peptide arrays identify isoform-selective substrates for profiling endogenous lysine deacetylase activity. | 2010-09-17 |
|
| Novel tricyclic pyrazole BRAF inhibitors with imidazole or furan central scaffolds. | 2010-09-15 |
|
| Carbodiimide insertion reactions of homoleptic heavier alkaline earth amides and phosphides. | 2010-08-21 |
|
| Total synthesis and antimicrobial activity of a natural cycloheptapeptide of marine origin. | 2010-08-19 |
|
| Influence of fluorophore and linker composition on the pharmacology of fluorescent adenosine A1 receptor ligands. | 2010-02 |
|
| Adsorption of Cu(II), Cd(II) and Pb(II) from aqueous single metal solutions by succinylated twice-mercerized sugarcane bagasse functionalized with triethylenetetramine. | 2009-10 |
|
| (S)-Methyl 2-[(3R,4R)-2-benzyl-3-(2-fur-yl)-1-oxo-1,2,3,4-tetra-hydro-isoquinoline-4-carboxamido]-3-(1H-indol-3-yl)propanoate. | 2009-06-06 |
|
| Synthesis and application of N-[1-(4-(4-fluorophenyl)-2,6-dioxocyclohexylidene)ethyl] (Fde)-protected amino acids for optimization of solid-phase peptide synthesis using gel-phase (19)F NMR spectroscopy. | 2009-04 |
|
| Total synthesis and biological potential of psammosilenin A. | 2008-08 |
|
| Mixed amido/imido/guanidinato complexes of niobium: potential precursors for MOCVD of niobium nitride thin films. | 2008-07-28 |
|
| C-H activation motivated by N,N'-diisopropylcarbodiimide within a lutetium complex stabilized by an amino-phosphine ligand. | 2007-10-10 |
|
| Toxicology study of diispropylcarbodiimide (CAS No. 693-13-0) in genetically modified (FVB Tg.AC Hemizygous) mice and carcinogenicity study of diispropylcarbodiimide in genetically modified [B6.129-Trp53tm1Brd (N5) haploinsufficient] mice (dermal studies). | 2007-03 |
|
| Toxicology and carcinogenesis studies of diisopropylcarbodiimide (Cas No. 693-13-0) in F344/N rats and B6C3F1 mice (dermal studies). | 2007-02 |
|
| Guanidinate-stabilized monomeric hafnium amide complexes as promising precursors for MOCVD of HfO2. | 2006-12-25 |
|
| Carbodiimide-based benzimidazole library method. | 2006-11-14 |
|
| Synthesis of polymer-bound 4-acetoxy-3-phenylbenzaldehyde derivatives: applications in solid-phase organic synthesis. | 2006-09-29 |
|
| A Src-like inactive conformation in the abl tyrosine kinase domain. | 2006-05 |
|
| Synthesis of methylenebis(phosphonate) analogs of dinucleotide pyrophosphates. | 2006-04 |
|
| Search for optimal coupling reagent in multiple peptide synthesizer. | 2006 |
|
| A "nanonecklace" synthesized from monofunctionalized gold nanoparticles. | 2005-06-08 |
|
| NK105, a paclitaxel-incorporating micellar nanoparticle formulation, can extend in vivo antitumour activity and reduce the neurotoxicity of paclitaxel. | 2005-04-11 |
|
| Biodegradable polymer releasing antibiotic developed for drainage catheter of cerebrospinal fluid: in vitro results. | 2005-04 |
|
| Theoretical and synthetic investigations of carbodiimide insertions into Al-CH3 and Al-N(CH3)2 bonds. | 2005-03-21 |
|
| Exploring the role of a unique carboxyl residue in EmrE by mass spectrometry. | 2005-03-04 |
|
| Reactivity of organolanthanide and organolithium complexes containing the guanidinate ligands toward isocyanate or carbodiimide: synthesis and crystal structures. | 2005-02-07 |
|
| Solid-phase synthesis of 1,2,3,4-tetrahydroisoquinoline derivatives employing support-bound tyrosine esters in the Pictet-Spengler reaction. | 2004-07-13 |
|
| DNA display III. Solid-phase organic synthesis on unprotected DNA. | 2004-07 |
|
| New mixed phosphonate esters by transesterification of pinacol phosphonates and their use in aldehyde and ketone coupling reactions with nonstabilized phosphonates. | 2003-02-21 |
|
| A new Horner-Wadsworth-Emmons type coupling reaction between nonstabilized beta-hydroxy phosphonates and aldehydes or ketones. | 2003-02-19 |
|
| A novel stereoselective one-pot conversion of alcohols into alkyl halides mediated by N,N'-diisopropylcarbodiimide. | 2003-01-21 |
|
| Synthesis of starch derivatives with labile cationic groups. | 2003-01-15 |
|
| Practical protocols for stepwise solid-phase synthesis of cysteine-containing peptides. | 2002-11 |
|
| MHC restriction in contact hypersensitivity to dicyclohexylcarbodiimide. | 2002-11 |
|
| Catalytic double-bond metathesis without the transition metal. | 2002-09-11 |
|
| Design and synthesis of a combinatorial chemistry library of 7-acyl, 10-acyl, and 7,10-diacyl analogues of paclitaxel (taxol) using solid phase synthesis. | 2002-08 |
|
| Modification of the swern oxidation: use of a recyclable, polystyrene bound sulfoxide. | 2002-07-22 |
|
| Novel mycophenolic adenine bis(phosphonate) analogues as potential differentiation agents against human leukemia. | 2002-01-31 |
|
| An alternative solid phase peptide fragment condensation protocol with improved efficiency. | 2001-10 |
|
| Solid-phase synthesis of cyclic analogues related to the hypoglycaemic peptide hGH(6-13): comparison of two i-->i + 4 lactam cyclization procedures. | 2001-10 |
|
| Structure-activity studies leading to ethambutol, a new type of antituberculous compound. | 1966-04-20 |
Patents
| Name | Type | Language | ||
|---|---|---|---|---|
|
Systematic Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
53092
Created by
admin on Mon Mar 31 19:16:03 GMT 2025 , Edited by admin on Mon Mar 31 19:16:03 GMT 2025
|
PRIMARY | |||
|
8051
Created by
admin on Mon Mar 31 19:16:03 GMT 2025 , Edited by admin on Mon Mar 31 19:16:03 GMT 2025
|
PRIMARY | |||
|
12734
Created by
admin on Mon Mar 31 19:16:03 GMT 2025 , Edited by admin on Mon Mar 31 19:16:03 GMT 2025
|
PRIMARY | |||
|
42080
Created by
admin on Mon Mar 31 19:16:03 GMT 2025 , Edited by admin on Mon Mar 31 19:16:03 GMT 2025
|
PRIMARY | |||
|
693-13-0
Created by
admin on Mon Mar 31 19:16:03 GMT 2025 , Edited by admin on Mon Mar 31 19:16:03 GMT 2025
|
PRIMARY | |||
|
DTXSID4025086
Created by
admin on Mon Mar 31 19:16:03 GMT 2025 , Edited by admin on Mon Mar 31 19:16:03 GMT 2025
|
PRIMARY | |||
|
m4488
Created by
admin on Mon Mar 31 19:16:03 GMT 2025 , Edited by admin on Mon Mar 31 19:16:03 GMT 2025
|
PRIMARY | Merck Index | ||
|
211-743-7
Created by
admin on Mon Mar 31 19:16:03 GMT 2025 , Edited by admin on Mon Mar 31 19:16:03 GMT 2025
|
PRIMARY | |||
|
OQO20I6TWH
Created by
admin on Mon Mar 31 19:16:03 GMT 2025 , Edited by admin on Mon Mar 31 19:16:03 GMT 2025
|
PRIMARY | |||
|
N,N'-Diisopropylcarbodiimide
Created by
admin on Mon Mar 31 19:16:03 GMT 2025 , Edited by admin on Mon Mar 31 19:16:03 GMT 2025
|
PRIMARY |
SUBSTANCE RECORD